Cargando…
The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease
The early diagnosis of Alzheimer’s disease (AD) has become important to the reversal and treatment of neurodegeneration, which may be relevant to premature brain aging that is associated with chronic disease progression. Clinical proteomics allows the detection of various proteins in fluids such as...
Autor principal: | Martins, Ian James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217345/ https://www.ncbi.nlm.nih.gov/pubmed/28248224 http://dx.doi.org/10.3390/proteomes4020014 |
Ejemplares similares
-
Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
por: Tiwari, Virendra, et al.
Publicado: (2023) -
Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022) -
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
por: Huynh, Kevin, et al.
Publicado: (2020) -
Genomic, proteomic and lipidomic evaluation of endometrial receptivity
por: Demiral, İrem, et al.
Publicado: (2015) -
Lipidomics of Alzheimer's disease: current status
por: Wood, Paul L
Publicado: (2012)